M.C. de Vernejoul

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

Jean‐Yves Reginster, Ego Seeman, M.C. de Vernejoul et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 1.1K citations · Full text

Quality of Life in Patients with Vertebral Fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO)

Paul Lips, Cyrus Cooper, D. Agnusdei et al. · Osteoporosis International · 1999 · 404 citations

Bone Disease, Quality Of Life, Life Assessment +12

Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis—A 2-Year Randomized Placebo Controlled Trial

P. J. Meunier, Daniel O. Slosman, Pierre D. Delmas et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 317 citations · Full text

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.

Pablo Ureña, M Hrubý, Aníbal Ferreira et al. · Journal of the American Society of Nephrology · 1996 · 256 citations · Full text

Dialysis Therapy, Hemodialysis Patients, Plasma Bap +17

Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients

Olivier Bénichou, Jean‐Denis Laredo, M.C. de Vernejoul · Bone · 2000 · 236 citations

Systemic Scleroderma, Radiological Manifestations, Albers-schönberg Disease +3